ScholarWorks@성균관대학교

상세 보기

Phase 3 eVOLVE-Lung02 Trial of Volrustomig plus Chemotherapy (CT) vs Pembrolizumab plus CT in Metastatic NSCLC With PD-L1 TC <50%

Johnson, M. L.;
Arriola, E.;
Kato, T.;
Girard, N.;
Gadgeel, S.;
외 9명

Citations

WEB OF SCIENCE

0

Citations

SCOPUS

0

제목: Phase 3 eVOLVE-Lung02 Trial of Volrustomig plus Chemotherapy (CT) vs Pembrolizumab plus CT in Metastatic NSCLC With PD-L1 TC <50%

저자: Johnson, M. L.; Arriola, E.; Kato, T.; Girard, N.; Gadgeel, S.; Tarruella, M. Majem; Newsom-Davis, T.; Polaczek, M.; Chen, X.; Stefaniak, K.; Lowery, C.; Angra, N.; Doherty, G.; Ahn, M-j.

발행일: 2025-10

유형: Meeting Abstract

저널명: Journal of Thoracic Oncology

권: 20

호: 10